Adaptive Biotechnologies Corp Stock Pattern Recognition Morning Star

ADPT Stock  USD 2.40  0.06  2.56%   
Adaptive Biotechnologies pattern recognition tool provides the execution environment for running the Morning Star recognition and other technical functions against Adaptive Biotechnologies. Adaptive Biotechnologies value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Morning Star recognition function is designed to identify and follow existing trends. Adaptive Biotechnologies momentum indicators are usually used to generate trading rules based on assumptions that Adaptive Biotechnologies trends in prices tend to continue for long periods. Please specify Penetration to run this model.

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Morning Star pattern describes Adaptive Biotechnologies bottom bullish reversal signal.

Adaptive Biotechnologies Technical Analysis Modules

Most technical analysis of Adaptive Biotechnologies help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Adaptive from various momentum indicators to cycle indicators. When you analyze Adaptive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Adaptive Biotechnologies Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adaptive Biotechnologies Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Adaptive Biotechnologies Corp based on widely used predictive technical indicators. In general, we focus on analyzing Adaptive Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Adaptive Biotechnologies's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Adaptive Biotechnologies's intrinsic value. In addition to deriving basic predictive indicators for Adaptive Biotechnologies, we also check how macroeconomic factors affect Adaptive Biotechnologies price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover14.917.1612.677.5
Days Of Inventory On Hand142.6191.153.9351.23
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adaptive Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.132.577.71
Details
Intrinsic
Valuation
LowRealHigh
0.244.799.93
Details
8 Analysts
Consensus
LowTargetHigh
11.0512.1413.48
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.34-0.33-0.31
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Adaptive Biotechnologies. Your research has to be compared to or analyzed against Adaptive Biotechnologies' peers to derive any actionable benefits. When done correctly, Adaptive Biotechnologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Adaptive Biotechnologies.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Adaptive Biotechnologies is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adaptive Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adaptive Biotechnologies Corp Stock. Highlighted below are key reports to facilitate an investment decision about Adaptive Biotechnologies Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Adaptive Stock analysis

When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.56)
Revenue Per Share
1.179
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.17)
Return On Equity
(0.58)
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.